Cite
HARVARD Citation
Burbage, S. et al. (n.d.). Clinical surveillance and PSA outcomes among patients with non-metastatic castration resistant prostate cancer (nmCRPC) treated with a next-generation androgen receptor inhibitor (ARI) in urology clinics with or without in-office dispensing (IOD).. Journal of clinical oncology. 40 (28), p. 410. [Online].